Wenn Sie das Fenster schließen, wird Ihre Konfiguration nicht gespeichert, es sei denn, Sie haben Ihren Artikel in die Bestellung aufgenommen oder zu Ihren Favoriten hinzugefügt.
Klicken Sie auf OK, um das MILLIPLEX® MAP-Tool zu schließen oder auf Abbrechen, um zu Ihrer Auswahl zurückzukehren.
Wählen Sie konfigurierbare Panels & Premixed-Kits - ODER - Kits für die zelluläre Signaltransduktion & MAPmates™
Konfigurieren Sie Ihre MILLIPLEX® MAP-Kits und lassen sich den Preis anzeigen.
Konfigurierbare Panels & Premixed-Kits
Unser breites Angebot enthält Multiplex-Panels, für die Sie die Analyten auswählen können, die am besten für Ihre Anwendung geeignet sind. Unter einem separaten Register können Sie das Premixed-Cytokin-Format oder ein Singleplex-Kit wählen.
Kits für die zelluläre Signaltransduktion & MAPmates™
Wählen Sie gebrauchsfertige Kits zur Erforschung gesamter Signalwege oder Prozesse. Oder konfigurieren Sie Ihre eigenen Kits mit Singleplex MAPmates™.
Die folgenden MAPmates™ sollten nicht zusammen analysiert werden: -MAPmates™, die einen unterschiedlichen Assaypuffer erfordern. -Phosphospezifische und MAPmate™ Gesamtkombinationen wie Gesamt-GSK3β und Gesamt-GSK3β (Ser 9). -PanTyr und locusspezifische MAPmates™, z.B. Phospho-EGF-Rezeptor und Phospho-STAT1 (Tyr701). -Mehr als 1 Phospho-MAPmate™ für ein einziges Target (Akt, STAT3). -GAPDH und β-Tubulin können nicht mit Kits oder MAPmates™, die panTyr enthalten, analysiert werden.
.
Bestellnummer
Bestellinformationen
St./Pkg.
Liste
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Wählen Sie bitte Spezies, Panelart, Kit oder Probenart
Um Ihr MILLIPLEX® MAP-Kit zu konfigurieren, wählen Sie zunächst eine Spezies, eine Panelart und/oder ein Kit.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Spezies
Panelart
Gewähltes Kit
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
96-Well Plate
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
Weitere Reagenzien hinzufügen (MAPmates erfordern die Verwendung eines Puffer- und Detektionskits)
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Platzsparende Option Kunden, die mehrere Kits kaufen, können ihre Multiplex-Assaykomponenten in Kunststoffbeuteln anstelle von Packungen erhalten, um eine kompaktere Lagerung zu ermöglichen.
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Das Produkt wurde in Ihre Bestellung aufgenommen
Sie können nun ein weiteres Kit konfigurieren, ein Premixed-Kit wählen, zur Kasse gehen oder das Bestell-Tool schließen.
Modified gastrin analog that serves as a general substrate for tyrosine kinases. Contains one phosphorylation site per molecule.
Catalogue Number
PK02
Brand Family
Calbiochem®
References
References
Guan, K.L., et al. 1991. Nature350, 359.
Product Information
Form
Lyophilized
Formulation
Lyophilized in a volatile buffer, BSA.
Positive control
Protein-Tyrosine Kinase, (p60c-src), Cat. No. PK03, and Raytide™, Cat. No. PK02, a substrate for tyrosine kinases, can serve as positive controls in experiments measuring protein phosphorylation.
Applications
Application Notes
Kinase Assay
Application Comments
Activity of p60c-src can be measured as described below using Raytide™, other peptide substrates and many naturally occurring proteins. This preparation of p60c-src has no detectable Ser or Thr kinase activity.
Suggested Kinase Reaction Protocol
Materials required:
[γ-32P]ATP (10 mCi/ml).
Kinase Assay Buffer: 50 mM HEPES, pH 7.5 containing 0.1 mM EDTA and 0.015% Brij 35.
Kinase Dilution Buffer: kinase assay buffer containing 0.1 mg/ml BSA and 0.2%
β-mercaptoethanol (note: β-mercaptoethanol is required for src kinase activity).
ATP Mix: 0.15 mM ATP, 30 mM MgCl2 and 200 mCi/ml [γ-32P]ATP in kinase assay buffer.
Phosphoric acid
Acetone
P81 Ion Exchange Chromatography paper (i.e. Whatman No. 3698915).
Procedure:
1. Dilute p60c-src stock solution to 0.2 units/μl in Kinase Dilution Buffer.
2. Mix 10 μl diluted p60c-src with 10 μl Raytide™ (1 mg/ml solution in Kinase Assay Buffer).
3. Start the reaction by adding 10 μl of ATP Mix.
4. Incubate at 30°C for 30 minutes.
5. Stop the reaction by adding 120 μl of 10% phosphoric acid. Vortex and apply 120 μl onto a square (2 cm x 2 cm) of P81 paper.
6. Wash papers extensively in 0.5% phosphoric acid. Wash once with acetone. Dry and quantitate by liquid scintillation counting. (Phosphorylated Raytide™ will stick, while ATP will wash off the papers).
Notes:
Each unit of p60c-src enzyme catalyzes the incorporation of one pmol phosphate per minute from ATP into tyrosyl residues.
In addition to phosphorylating Raytide™, the p60c-src protein-tyrosine kinase can be used to phosphorylate many naturally occurring proteins.
Natural substrates phosphorylated on tyrosyl residues may be purified from complex mixtures using the Immunoaffinity System for purification of phosphotyrosyl proteins (Cat. No. PTS01).
In addition to being phosphorylated by p60c-src, Raytide™ can be used as a substrate for many naturally occurring tyrosine kinases.
Raytide™ contains BSA.
Raytide™ control peptide (without a tyrosine, Cat. No. PK05) is also available.
To use Raytide™ in a dephosphorylation assay with tyrosine phosphatases, see Nature 350, 359-62, 1991.
Biological Information
Purity
>98% by SDS-PAGE
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code
Blue Ice Only
Toxicity
Standard Handling
Storage
+2°C to +8°C
Avoid freeze/thaw
Avoid freeze/thaw
Do not freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C) or refrigerate (4°C) with 0.1% azide. Stock solutions are stable for up to 3 months at -20°C. Avoid freeze/thaw cycles of solutions.
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
Revision
18-September-2008 RFH
Application
Kinase Assay
Description
Raytide™ is a modified gastrin analog. There is one tyrosyl phosphorylation site per Raytide™ molecule. The carboxyl end of the peptide contains acidic and hydrophilic amino acid residues, while the amino terminus contains basic amino acids. In phosphoric acid the amino end is positively charged and binds to phosphocellulose paper (p81 Whatman). The distance between the two charged ends of the peptide prevents neutralization. Additionally, the peptide maintains an unfolded state and functions as an excellent substrate for protein-tyrosine kinases and tyrosine phosphatases (Nature 350, 359-62, 1991). Raytide™ EL, Cat. No. PK04, which has a higher labeling efficiency when used as either a kinase or a phosphatase substrate is also available.
Note: the exact sequence of Raytide™ and Raytide™ EL is proprietary to Calbiochem and cannot be released.
Background
Raytide™ is a modified gastrin analog. There is one tyrosyl phosphorylation site per Raytide™ molecule. The carboxyl end of the peptide contains acidic and hydrophilic amino acid residues, while the amino terminus contains basic amino acids. In phosphoric acid the amino end is positively charged and binds to phosphocellulose paper (p81 Whatman). The distance between the two charged ends of the peptide prevents neutralization. Additionally, the peptide maintains an unfolded state and functions as an excellent substrate for protein-tyrosine kinases and tyrosine phosphatases (Nature 350, 359-62, 1991). Raytide™ EL, Cat. No. PK04, which has a higher labeling efficiency when used as either a kinase or a phosphatase substrate is also available.
Note: the exact sequence of Raytide™ and Raytide™ EL is proprietary to Calbiochem and cannot be released.
Positive control
Protein-Tyrosine Kinase, (p60c-src), Cat. No. PK03, and Raytide™, Cat. No. PK02, a substrate for tyrosine kinases, can serve as positive controls in experiments measuring protein phosphorylation.
Form
Lyophilized
Formulation
Lyophilized in a volatile buffer, BSA.
Recommended reaction conditions
Suggested Kinase Protocol
Materials required:
• [γ-32P]ATP (10 mCi/ml).
• Kinase Assay Buffer: 50 mM HEPES, pH 7.5 containing 0.1 mM EDTA and 0.015% Brij®-35 detergent.
• Kinase Dilution Buffer: kinase assay buffer containing 0.1 mg/ml BSA and 0.2%
β-mercaptoethanol (note: β-mercaptoethanol is required for src kinase activity).
• ATP Mix: 0.15 mM ATP, 30 mM MgCl2 and 200 mCi/ml [γ-32P]ATP in kinase assay buffer.
• Phosphoric acid
• Acetone
• P81 Ion Exchange Chromatography paper (i.e. Whatman No. 3698915).
Procedure:
1. Dilute p60c-src stock solution to 0.2 units/µl in Kinase Dilution Buffer.
2. Mix 10 µl diluted p60c-src with 10 µl Raytide™ (1 mg/ml solution in Kinase Assay Buffer).
3. Start the reaction by adding 10 µl of ATP Mix.
4. Incubate at 30°C for 30 min.
5. Stop the reaction by adding 120 µl of 10% phosphoric acid. Vortex and apply 120 µl onto a square (2 cm x 2 cm) of P81 paper.
6. Wash papers extensively in 0.5% phosphoric acid. Wash once with acetone. Dry and quantitate by liquid scintillation counting. (Phosphorylated Raytide™ will stick, while ATP will wash off the papers).
Notes:
In addition to being phosphorylated by p60c-src, Raytide™ can be used as a substrate for many naturally occurring tyrosine kinases.
Raytide™ control peptide (without a tyrosine, Cat. No. PK05) is also available.
To use Raytide™ in a dephosphorylation assay with tyrosine phosphatases, see Nature 350, 359-62, 1991.
Purity
>98% by SDS-PAGE
Solubility
Aqueous Buffers (1 mg/ml)
Comments
Activity of p60c-src can be measured as described below using Raytide™, other peptide substrates and many naturally occurring proteins. This preparation of p60c-src has no detectable Ser or Thr kinase activity.
Suggested Kinase Reaction Protocol
Materials required:
[γ-32P]ATP (10 mCi/ml).
Kinase Assay Buffer: 50 mM HEPES, pH 7.5 containing 0.1 mM EDTA and 0.015% Brij 35.
Kinase Dilution Buffer: kinase assay buffer containing 0.1 mg/ml BSA and 0.2%
β-mercaptoethanol (note: β-mercaptoethanol is required for src kinase activity).
ATP Mix: 0.15 mM ATP, 30 mM MgCl2 and 200 mCi/ml [γ-32P]ATP in kinase assay buffer.
Phosphoric acid
Acetone
P81 Ion Exchange Chromatography paper (i.e. Whatman No. 3698915).
Procedure:
1. Dilute p60c-src stock solution to 0.2 units/μl in Kinase Dilution Buffer.
2. Mix 10 μl diluted p60c-src with 10 μl Raytide™ (1 mg/ml solution in Kinase Assay Buffer).
3. Start the reaction by adding 10 μl of ATP Mix.
4. Incubate at 30°C for 30 minutes.
5. Stop the reaction by adding 120 μl of 10% phosphoric acid. Vortex and apply 120 μl onto a square (2 cm x 2 cm) of P81 paper.
6. Wash papers extensively in 0.5% phosphoric acid. Wash once with acetone. Dry and quantitate by liquid scintillation counting. (Phosphorylated Raytide™ will stick, while ATP will wash off the papers).
Notes:
Each unit of p60c-src enzyme catalyzes the incorporation of one pmol phosphate per minute from ATP into tyrosyl residues.
In addition to phosphorylating Raytide™, the p60c-src protein-tyrosine kinase can be used to phosphorylate many naturally occurring proteins.
Natural substrates phosphorylated on tyrosyl residues may be purified from complex mixtures using the Immunoaffinity System for purification of phosphotyrosyl proteins (Cat. No. PTS01).
In addition to being phosphorylated by p60c-src, Raytide™ can be used as a substrate for many naturally occurring tyrosine kinases.
Raytide™ contains BSA.
Raytide™ control peptide (without a tyrosine, Cat. No. PK05) is also available.
To use Raytide™ in a dephosphorylation assay with tyrosine phosphatases, see Nature 350, 359-62, 1991.
Storage
Avoid freeze/thaw
+2°C to +8°C
Do Not Freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C) or refrigerate (4°C) with 0.1% azide. Stock solutions are stable for up to 3 months at -20°C. Avoid freeze/thaw cycles of solutions.